首页> 美国卫生研究院文献>PLoS Biology >Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies
【2h】

Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies

机译:两年后:期刊尚未执行临床前动物研究报告标准的ARRIVE指南

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is growing concern that poor experimental design and lack of transparent reporting contribute to the frequent failure of pre-clinical animal studies to translate into treatments for human disease. In 2010, the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines were introduced to help improve reporting standards. They were published in PLOS Biology and endorsed by funding agencies and publishers and their journals, including PLOS, Nature research journals, and other top-tier journals. Yet our analysis of papers published in PLOS and Nature journals indicates that there has been very little improvement in reporting standards since then. This suggests that authors, referees, and editors generally are ignoring guidelines, and the editorial endorsement is yet to be effectively implemented.
机译:人们越来越担心,不良的实验设计和缺乏透明的报告会导致临床前动物研究经常无法转化为人类疾病的治疗方法。 2010年,引入了《动物研究:体内实验报告》(ARRIVE)指南,以帮助提高报告标准。它们发表在《 PLOS Biology》上,并得到了资助机构和出版商及其期刊的认可,包括PLOS,《自然》研究期刊和其他顶级期刊。然而,我们对在PLOS和Nature期刊上发表的论文的分析表明,自那时以来,报告标准几乎没有改善。这表明作者,裁判和编辑通常都忽略了指导方针,而编辑背书仍有待有效实施。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号